Comorbidity-adjusted survival in early stage lung cancer patients treated with hypofractionated proton therapy

Journal of Oncology

Volumn , Issue , 2010, Pages

  Bush, David A ^a   Do, Sharon Y ^a   Slater, Jerry D ^a  

^a LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; COMORBIDITY; EARLY CANCER; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PHASE 2 CLINICAL TRIAL (TOPIC); PREDICTION; PROSPECTIVE STUDY; PROTON THERAPY; RADIATION DOSE FRACTIONATION; RETROSPECTIVE STUDY;

EID: 79251611878     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2010/251208     Document Type: Article

References (12)

1. American Cancer Society,. October 2008, http://www.cancer.org/Cancer/ LungCancer-SmallCell/OverviewGuide/lung-cancer-small-cell-overview-key- statistics
2. Fakiris A. J., McGarry R. C., Yiannoutsos C. T., Papiez L., Williams M., Henderson M. A., Timmerman R., Stereotactic body radiation therapy for early-stage nonsmall-cell lung carcinoma: four-year results of a prospective phase II study International Journal of Radiation Oncology Biology Physics 2009 75 3 677 682
3. Salazar O. M., Sandhu T. S., Lattin P. B., Chang J. H., Lee C. K., Groshko G. A., Lattin C. J., Once-weekly, high-dose stereotactic body radiotherapy for lung cancer: 6-year analysis of 60 early-stage, 42 locally advanced and 7 metastatic lung cancers International Journal of Radiation Oncology Biology Physics 2008 72 3 707 715
4. Uematsu M., Shioda A., Suda A., Fukui T., Ozeki Y., Hama Y., Wong J. R., Kusano S., Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience International Journal of Radiation Oncology Biology Physics 2001 51 3 666 670
5. Charlson M. E., Pompei P., Ales K. A., MacKenzie C. R., A new method of classifying prognostic comorbidity in longitudinal studies: development and validation Journal of Chronic Diseases 1987 40 5 373 383
6. Bush D. A., Slater J. D., Shin B. B., Cheek G., Miller D. W., Slater J. M., Hypofractionated proton beam radiotherapy for stage I lung cancer Chest 2004 126 4 1198 1203
7. Birim., Maat A. P. W. M., Kappetein A. P., Van Meerbeeck J. P., Damhuis R. A. M., Bogers A. J. J. C., Validation of the Charlson comorbidity index in patients with operated primary non-small cell lung cancer European Journal of Cardio-Thoracic Surgery 2003 23 1 30 34
8. Hall W. H., Jani A. B., Ryu J. K., Narayan S., Vijayakumar S., The impact of age and comorbidity on survival outcomes and treatment patterns in prostate cancer Prostate Cancer and Prostatic Diseases 2005 8 1 22 30
9. Hall W. H., Ramachandran R., Narayan S., Jani A. B., Vijayakumar S., An electronic application for rapidly calculating Charlson comorbidity score BMC Cancer 2004 4, article no. 94
10. Rowell N. P., Williams C. J., Radical radiotherapy for stage I/II non-small cell lung cancer in patients not sufficiently fit for or declining surgery (medically inoperable): a systematic review Thorax 2001 56 8 628 638
11. Zimmermann F. B., Bamberg M., Molls M., Jeremic B., Radiation therapy alone in early stage non-small cell lung cancer Seminars in Surgical Oncology 2003 21 2 91 97
12. Chang J. Y., Zhang X., Wang X., Kang Y., Riley B., Bilton S., Mohan R., Komaki R., Cox J. D., Significant reduction of normal tissue dose by proton radiotherapy compared with three-dimensional conformal or intensity-modulated radiation therapy in Stage I or Stage III non-small-cell lung cancer International Journal of Radiation Oncology Biology Physics 2006 65 4 1087 1096